The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

The US Food and Drug Association gave full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday for individuals older than sixteen years. Previously, the treatment was only administered under an emergency use authorization (EUA), which was granted in December 2020.

3 COVID-19 vaccines move forward after promising Phase 3 clinical trial data

by Mark Hu and Sabrina Zhu December 2, 2020

Biotechnology companies Pfizer, Moderna and AstraZeneca released first interim analysis reports from Phase 3 trials of their respective COVID-19 vaccines, all within the past month. The vaccines have efficacy...

In the United States, three companies — Moderna, Pfizer and AstraZeneca — have been conducting Phase 3 trials for a coronavirus vaccine. Phase 3 trials are the last step before a vaccine can be approved, with 30,000 volunteers participating in a study testing the efficacy of each vaccine.

SARS-CoV-2 vaccines continue Phase 3 trials, testing

by Aditya Singhvi, Aquila Co-Managing Editor September 28, 2020

As the coronavirus pandemic continues to expand, scientists around the globe are racing to develop and test an effective vaccine that can be approved for widespread use. In the United States, three...

Whether or not these doctors are motivated by altruism or reckless self-interest, one thing is clear: scientists who promote experimental vaccines as valid drugs blur the boundary between medicine and quackery, subjecting unaware citizens to unanticipated harm.

Promoting experimental vaccines isn’t science – it’s medical fraud

by Nicholas Wei, Humans of Harker Staff Writer September 9, 2020

As the notoriously slow process of Covid-19 vaccine approval drags on, groups of scientists have begun developing their own experimental SARS-CoV-2 vaccines, citing its supposed benefits on themselves,...

Load More Stories